Literature DB >> 18799028

[Promoter methylation of DAPK gene in cervical carcinoma].

Xian-Lan Zhao1, Zhi-Ying Meng, Yu-Huan Qiao, Hui-Li Zhang.   

Abstract

BACKGROUND &
OBJECTIVE: Aberrant DNA methylation plays important roles during multistage carcinogenesis in various human organs. This study was to explore the relationship between the promoter methylation and inactivation of DAPK gene in cervical cancer.
METHODS: The promoter methylation of DAPK was investigated with methylation-specific polymerase chain reaction (MSP) in 52 specimens of cervical cancer, 60 specimens of cervical intraepithelial neoplasia (CIN) and 20 specimens of normal cervical squamous epithelial tissues. Its correlation to clinicopathologic features of cervical cancer was analyzed. The protein expression of DAPK was detected by immunohistochemistry.
RESULTS: The methylation rate of DAPK gene promoter was significantly higher in cervical cancer tissues than in CIN (65.4% vs. 18.3%, P<0.05); while no methylation of DAPK gene was found in normal cervical tissues. The methylation rate of DAPK gene was significantly higher in cervical squamous cell carcinomas than in adenocarcinomas (80.0% vs. 16.7%, P<0.001). Promoter methylation of DAPK was negatively correlated to its protein expression (r=-0.849, P<0.001).
CONCLUSION: The promoter methylation may lead to inactivation of DAPK gene, and may be related with tumorigenesis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799028

Source DB:  PubMed          Journal:  Ai Zheng


  6 in total

1.  Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.

Authors:  Chiaki Banzai; Koji Nishino; Jinhua Quan; Kosuke Yoshihara; Masayuki Sekine; Tetsuro Yahata; Kenichi Tanaka
Journal:  Int J Clin Oncol       Date:  2013-03-14       Impact factor: 3.402

2.  Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis.

Authors:  Jiaqiang Xiong; Ya Li; Kecheng Huang; Meixia Lu; Hao Shi; Lanfang Ma; Aiyue Luo; Shuhong Yang; Zhiyong Lu; Jinjin Zhang; Lilan Yang; Shixuan Wang
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

3.  Identification of DAPK1 Promoter Hypermethylation as a Biomarker for Intra-Epithelial Lesion and Cervical Cancer: A Meta-Analysis of Published Studies, TCGA, and GEO Datasets.

Authors:  Xue-Bin Wang; Ning-Hua Cui; Xia-Nan Liu; Jun-Fen Ma; Qing-Hua Zhu; Shu-Ren Guo; Jun-Wei Zhao; Liang Ming
Journal:  Front Genet       Date:  2018-07-17       Impact factor: 4.599

4.  Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir

Authors:  Asia Asiaf; Shiekh Tanveer Ahmad; Ajaz Ahmad Malik; Shiekh Aejaz Aziz; Mohammad Afzal Zargar
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

Review 5.  DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis.

Authors:  Antonella Agodi; Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Manlio Vinciguerra
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

6.  mRNA expression and hypermethylation of tumor suppressor genes apoptosis protease activating factor-1 and death-associated protein kinase in oral squamous cell carcinoma.

Authors:  Chunyan Li; Lin Wang; Jing Su; Ruhui Zhang; Li Fu; Yanmin Zhou
Journal:  Oncol Lett       Date:  2013-05-17       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.